Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

DLHIX vs RYHIX overlap: 43% of top holdings shared

Bottom line

How much do DLHIX and RYHIX overlap?

43% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 35.8% of DLHIX's assets and 18.7% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.

Updated Nov 22, 2026

Overlap at a glance

DLHIXRYHIX
Weight overlap (top 25)43%
Shared holdings11
Weight in shared holdings35.8%18.7%
Total positions108135
Expense ratio0.96%1.38%
Holdings as ofJun 30, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Holdings DLHIX and RYHIX have in common

Holding% of DLHIX% of RYHIXOverlap
Abbvie Inc ABBV4.19%2.52%2.52%
Eli Lilly & Company LLY4.16%3.63%3.63%
Regeneron Pharmaceuticals Inc REGN3.91%0.90%0.90%
Unitedhealth Group Inc UNH3.88%2.22%2.22%
Pfizer Inc PFE3.84%1.25%1.25%
Merck & Company Inc MRK3.68%2.04%2.04%
Gilead Sciences Inc GILD3.54%1.39%1.39%
Elevance Health Inc ELV3.25%1.02%1.02%
Amgen Inc AMGN2.27%1.56%1.56%
Vertex Pharmaceuticals Inc VRTX1.66%1.34%1.34%
Boston Scientific Corp BSX1.42%0.86%0.86%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in DLHIX

  1. Ucb Sa — 5.19%
  2. Astrazeneca Plc — 3.27%
  3. Roche Holding Ag — 3.01%
  4. Chugai Pharmaceutical Co Ltd — 2.77%
  5. Viatris Inc — 2.48%
  6. Oruka Therapeutics Inc — 2.41%
  7. Halozyme Therapeutics Inc — 2.30%
  8. Illumina Inc — 2.11%
  9. Alkermes Plc — 1.82%
  10. Viking Therapeutics Inc — 1.72%
  11. Roivant Sciences Ltd — 1.60%
  12. Neurocrine Biosciences Inc — 1.57%
  13. Arcus Biosciences Inc — 1.56%
  14. Zimmer Biomet Holdings Inc — 1.42%

Only in RYHIX

  1. Johnson & Johnson — 2.88%
  2. Thermo Fisher Scientific Inc — 1.61%
  3. Abbott Laboratories — 1.42%
  4. Cvs Health Corp — 1.31%
  5. Intuitive Surgical Inc — 1.31%
  6. Danaher Corp — 1.30%
  7. Bristol-myers Squibb Company — 1.22%
  8. Stryker Corp — 1.21%
  9. Mckesson Corp — 1.05%
  10. Cigna Group (the) — 0.94%
  11. Hca Healthcare Inc — 0.87%
  12. Cardinal Health Inc — 0.86%
  13. Edwards Lifesciences Corp — 0.84%
  14. Novo Nordisk A/s — 0.83%

Asset mix

Asset typeDLHIXRYHIX
Stocks94.8%83.2%
Preferred stock3.0%—
Cash & short-term funds2.0%—
Repurchase agreements—0.9%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Country mix

CountryDLHIXRYHIX
US75.4%73.0%
BE5.2%—
IE3.2%3.3%
GB3.3%1.8%
CH3.0%2.3%
JP2.8%—
FR2.0%—
NL1.6%0.7%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do DLHIX and RYHIX overlap?
About 43% by weight. 11 securities appear in both funds' top 25 holdings; they make up 35.8% of DLHIX's assets and 18.7% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do DLHIX and RYHIX have in common?
The largest shared holdings are Eli Lilly & Company, Abbvie Inc, Unitedhealth Group Inc, Merck & Company Inc, Amgen Inc.
Should I own both DLHIX and RYHIX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, DLHIX or RYHIX?
RYHIX is broader, with 135 positions versus 108 for DLHIX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.